Dennis is CEO / Managing Partner of Axcelius LLC and advisory partner to Domain Associates. His board service or CEO leadership has resulted in many successful exits (Tobira/Allergan, Avanir/Otsuka, Corthera/ Novartis, Rightcare Solutions/Cardinal Health, Calixa/ Cubist, Cerexa/Forest, Peninsula/J&J). Previously, he held executive positions at Novartis, Allergan, and SKB.

• 

  Chief Executive Officer (CEO) in Transposon Therapeutics

  Transformational therapies for neurodegenerative and aging-related diseases

• 

  Chairman of the Board in Transposon Therapeutics

  Transformational therapies for neurodegenerative and aging-related diseases